Microbiome Drug Development in Asia Infographic
Covered in the Infographic:
- An overview of the Asian Microbiome market and it’s significance within the wider global space
- Analysis of the 160+ Asian companies tracked on Beacon Microbiome by company type and size, along with a look at funding type and potential deal value
- A deep dive into the most prominent disease targets and therapeutic classes in the Asian market
To learn more about the infographic and how Beacon Microbiome can enhance your data needs and provide fast insights, please book a research session below or contact us directly on beacon@hansonwade.com.
You May Also Be Interested In…
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
